
HealthEquity (HQY) Stock Forecast & Price Target
HealthEquity (HQY) Analyst Ratings
Bulls say
HealthEquity Inc. demonstrated strong financial performance, highlighted by a 13% year-over-year increase in custodial revenue and a remarkable adjusted EBITDA margin of 44.0%, reflecting a 466 basis points improvement. The company's cash flow from operations rose by 28.4%, reaching $339.2 million in FY/26, indicating a robust operational efficiency. Furthermore, total HSA assets increased to $36.5 billion, marking a 13.6% year-over-year growth, driven by higher balances per member and increased engagement, underscoring the company's strong position in the health savings sector.
Bears say
HealthEquity Inc. has projected FY/27 revenue of $1.410 billion, representing a modest 7.4% year-over-year increase, which is slightly below previous estimates, indicating potential revenue growth challenges. Additionally, the company's shares have declined by 13% year-to-date and are currently trading at multiples that suggest they are overvalued compared to both its high-growth peers and its historical valuation averages. Concerns surrounding industry competitiveness, regulatory uncertainties, reliance on external suppliers, and the potential impact of evolving healthcare policies further contribute to the negative outlook on HealthEquity's stock performance.
This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares